Article: Perrigo Announces FDA Approval for Generic Version of NASACORT AQ.

Article: New Data Presented at ACAAI Informs on the Safety and Efficacy of ...
PR Newswire;  November 10, 2007 ;     700+ words ... ... Showed That Over a 6 Month Period, Nasacort AQ Did Not Cause Significant Adrenal Suppression ... suggests that the intranasal corticosteroid Nasacort AQ (triamcinolone acetonide) Nasal Spray ... also showed that during the study, Nasacort AQ did not show a significant effect on ...

Article: FDA Approves Nasacort AQ(R) Nasal Spray for ...
PR Newswire;  September 23, 2008 ;     700+ words ... ... demonstrated both the efficacy and safety of Nasacort AQ(R) in children with nasal symptoms ... Administration (FDA) has approved Nasacort AQ Nasal Spray (triamcinolone acetonide ... controlled study demonstrating that Nasacort AQ can be used safely and effectively to ...

Article: New Trial Presented at AAAAI Reports that the Growth of Children ...
PR Newswire;  March 15, 2008 ;     700+ words ... ... continuous use of intranasal corticosteroid Nasacort AQ (triamcinolone acetonide) Nasal Spray ... that following 6 month treatment with Nasacort AQ, the stature-for-age distribution ... children were randomized to receive either Nasacort AQ 110 micrograms or placebo as 1 spray ...

Article: ViroPharma to Join Aventis in Promoting Allegra and ...
Immunotherapy Weekly;  January 16, 2002 ;     700+ words ... ... join Aventis to promote products from the Allegra family and Nasacort AQ to primary care physicians throughout the United States beginning ... allergy symptoms and chronic idiopathic urticaria (hives). Nasacort AQ is a once-daily corticosteroid nasal spray for the treatment ...

Nasacort AQ approvals.(NEWSLINE: Highlights of recent ...
Nurse Practitioners' Prescribing Reference;  December 22, 2008 ;     583 words ...Sanofi-aventis' Nasacort AQ (triamcinolone acetonide nasal spray) has been approved for the treatment of seasonal and perennial allergic rhinitis in children 2-5 years of age. For more information call (800) 446-6267.

Article: Sanofi settles litigation with Teva/Barr on generic Allegra and ...
Pharma Marketletter;  November 24, 2008 ;     481 words ... ... with Teva and Barr over the sales of their generic versions of the Allegra (fexofenadine) allergy product franchise and Nasacort AQ (triamcinolone acetonide) nasal spray. The latter will now be launched years prior to the expiration of its applicable ...

Article: RHONE-POULENC RORER RECEIVES APPROVABLE LETTER FROM FDA FOR ...
PR Newswire;  October 6, 1995 ;     700+ words ... ... New Drug Application (NDA) for Nasacort AQ, an intranasal steroid, was submitted ... evaluated the safety and efficacy of Nasacort AQ as a treatment of seasonal and perennial allergic rhinitis. Nasacort AQ's water-based, metered pump ...